Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Gender difference in arsenic biotransformation is an important metabolic basis for arsenic toxicity

Fig. 4

Liver MPO activity in each group. Data were expressed as mean ± standard deviation and analyzed by one-way variance analysis and LSD-t test. Compared with normal control group, P < 0.05; ▲Compared with low dose group,P < 0.05; Compared with different arsenic compounds in the same dose group, P < 0.05; ■Compared the male and female animals in the same group, P < 0.05

Back to article page